Analysis of the kinetics of osteoclastogenesis in arthritic rats

Arthritis and Rheumatism

Volumn 52, Issue 10, 2005, Pages 3192-3201

  Schett, Georg ^a,b   Stolina, Marina ^c   Bolon, Brad ^a,d   Middleton, Scot ^c   Adlam, Matt ^c   Brown, Heather ^c   Zhu, Li ^c   Feige, Ulrich ^c   Zack, Debra J ^a,c  

^a AMGEN INC   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ESBATech AG   (Switzerland)

^d GEMpath Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CARRAGEENAN; CATHEPSIN K; COLLAGEN;

ACUTE ARTHRITIS; ACUTE DISEASE; ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE PLATE; CELL KINETICS; CELL MATURATION; CELL NUCLEUS; CELL PROTECTION; CELL SIZE; CELLULAR DISTRIBUTION; CHRONIC ARTHRITIS; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE MODEL; EARLY DIAGNOSIS; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MACROPHAGE ACTIVATION; MALE; NONHUMAN; ONSET AGE; OSTEOCLAST; OSTEOLYSIS; PAW EDEMA; PERIOSTEUM; PRIORITY JOURNAL; RAT; SYNOVIUM; TIME;

ACUTE DISEASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE RESORPTION; CARRAGEENAN; CATHEPSINS; FEMALE; JOINTS; KINETICS; MACROPHAGES; MALE; MONOCYTES; OSTEOCLASTS; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE;

EID: 26844547431     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21343     Document Type: Article

References (30)

1. Goldring S. Osteoporosis and rheumatic diseases. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003. p. 379-81.
2. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000;39:122-32.
3. Pincus T. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988;41:1037-41.
4. Van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34:74-8.
5. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-9.
6. Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, et al. Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 2002;46:785-92.
7. Romas E, Sims NA, Hards DK, Lindsay M, Quinn JW, Ryan PF, et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 2002;161:1419-27.
8. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
9. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998;152:943-51.
10. Pap T, Aupperle KR, Gay S, Firestein GS, Gay RE. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum 2001;44:676-81.
11. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000;43:250-8.
12. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 2000;43:2523-30.
13. Lubberts E, Oppers-Walgreen B, Pettit AR, van den Bersselaar L, Joosten LA, Goldring SR, et al. Increase in expression of receptor activator of nuclear factor κB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. Arthritis Rheum 2002;46:3055-64.
14. Herrak P, Gortz B, Hayer S, Redlich K, Reiter E, Gasser J, et al. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis. Arthritis Rheum 2004; 50:2327-37.
15. Sims NA, Green JR, Glatt M, Schlict S, Martin TJ, Gillespie MT, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum 2004; 50:2338-46.
16. Goldring SR, Gravallese EM. Bisphosphonates: environmental protection for the joint? [editorial]. Arthritis Rheum 2004;50:2044-7.
17. Campagnuolo G, Bolon B, Feige U. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Arthritis Rheum 2002;46:1926-36.
18. Redlich K, Gortz B, Hayer S, Zwerina J, Warmington K, Kostenuik P, et al. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis. Am J Pathol 2004;164:543-5.
19. Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50:277-90.
20. Lubberts E, Joosten LA, Chabaud M, van den Bersselaar L, Oppers-Walgreen B, Coenen-de Roo CJ, et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 2000;105:1697-710.
21. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 2002;110:1419-27.
22. Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi Y, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001;159:1689-99.
23. Feige U, Hu YL, Gasser J, Campagnuolo G, Munyakazi L, Bolon B. Anti-interleukin-1 and anti-tumor necrosis factor-α synergistically inhibit adjuvant arthritis in Lewis rats. Cell Mol Life Sci 2000;57:1457-70.
24. Bolon B, Morony S, Cheng Y, Hu YL, Feige U. Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: identification of preferred sites and parameters for rapid quantitative analysis. Vet Pathol 2004;41:30-6.
25. Willoughby D. Carrageenan induced paw edema. In: Winyard PG, Willoughby DA, editors. Inflammation protocols. 1st ed. Totowa (NJ): Humana Press; 2003. p. 109-22.
26. Goldring SR. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2002;14:406-10.
27. Schett G, Redlich K, Smolen JS. The role of osteoprotegerin in arthritis. Arthritis Res Ther 2003;5:239-45.
28. McQueen F, Lassere M, Edmonds J, Conaghan P, Peterfy C, Bird P, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies: summary of OMERACT 6 MR imaging module. J Rheumatol 2003;30:1387-92.
29. Peterfy CG. New developments in imaging in rheumatoid arthritis. Curr Opin Rheumatol 2003;15:288-95.
30. Marinova-Mutafchieva L, Williams RO, Funa K, Maini RN, Zvaifler NJ. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002;46:507-13.